# Olema Pharmaceuticals, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/olema-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 27 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-22T04:46:19.057697+00:00 | | Last reviewed | 2026-10-22T04:46:19.057697+00:00 | ## Identity - Legal name: Olema Pharmaceuticals, Inc. - Display name: Olema Pharmaceuticals, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-22T04:46:19.057697+00:00 | | Completeness | 0.409 | | Record Quality | 0.831 | | Directors | 16 | | Committees | 2 | | Governance events | 9 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Andrew Rappaport: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2013-01-01. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:6 - Cynthia Butitta: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:7 - Cyrus L. Harmon: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2006-01-01. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:8 - Gorjan Hrustanovic: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:10 - Graham Walmsley: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:12 - Prakash Raman: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-01-01. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:14 - Sandra J. Horning: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:17 - Scott Garland: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:18 - Yi Larson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. Committees: Nominating and Committee (member). claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:20 - Cyrus L. Harmon, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:9 - Gorjan Hrustanovic, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:11 - Graham Walmsley, M.D., Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:13 - Ian Clark: Chairperson of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:5 - Prakash Raman, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:15 - Sandra Horning, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:16 - Sean Bohen, M.D., Ph.D.: Director, President and Chief Executive Officer. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: President and Chief Executive Officer (member). claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:19 ## Committees - Nominating and Committee (nominating_governance). Chair: NOT_PUBLISHED. Members: Yi Larson (member, current). committee_id=alpha:committee:olema-pharmaceuticals-inc:nominating-and-committee - President and Chief Executive Officer (executive). Chair: NOT_PUBLISHED. Members: Sean Bohen, M.D., Ph.D. (member, unknown). committee_id=alpha:committee:olema-pharmaceuticals-inc:president-and-chief-executive-officer ## Executive leadership - David C. Myles, Ph.D.: Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:21 - Naseem Zojwalla, M.D.: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:22 - Sean Bohen, M.D., Ph.D.: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:23 - Shane Kovacs: Chief Operating and Financial Officer. Status: unknown. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:24 - Shawnte M. Mitchell, J.D.: Chief Legal Officer and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:25 ## Governance events - DIRECTOR_APPOINTED: Prakash Raman seat on Olema Pharmaceuticals, Inc., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-22T04:46:19.057697+00:00. event_id=alpha:event:transition:12xpjisr952la - DIRECTOR_APPOINTED: Scott Garland seat on Olema Pharmaceuticals, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-22T04:46:19.057697+00:00. event_id=alpha:event:transition:pc0a8d1ynhq13 - DIRECTOR_APPOINTED: Yi Larson seat on Olema Pharmaceuticals, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-22T04:46:19.057697+00:00. event_id=alpha:event:transition:ir6x481ra5y8m - DIRECTOR_APPOINTED: Cynthia Butitta seat on Olema Pharmaceuticals, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:19.057697+00:00. event_id=alpha:event:transition:80ncsslciqxe - DIRECTOR_APPOINTED: Graham Walmsley seat on Olema Pharmaceuticals, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:19.057697+00:00. event_id=alpha:event:transition:1i5u4k0tdtqji - DIRECTOR_APPOINTED: Sandra J. Horning seat on Olema Pharmaceuticals, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-22T04:46:19.057697+00:00. event_id=alpha:event:transition:cz8dglbx9sbv - DIRECTOR_APPOINTED: Gorjan Hrustanovic seat on Olema Pharmaceuticals, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-22T04:46:19.057697+00:00. event_id=alpha:event:transition:d2zp7z136tmmz - DIRECTOR_APPOINTED: Andrew Rappaport seat on Olema Pharmaceuticals, Inc., effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-22T04:46:19.057697+00:00. event_id=alpha:event:transition:1n91j2p1mzj2z7 - DIRECTOR_APPOINTED: Cyrus L. Harmon seat on Olema Pharmaceuticals, Inc., effective 2006-01-01. Effective: 2006-01-01. Detected: 2026-10-22T04:46:19.057697+00:00. event_id=alpha:event:transition:hgz6bd17h04ad ## Scoped resources - `alpha://company/olema-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record - `alpha://company/olema-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/olema-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/olema-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=board - `alpha://company/olema-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/olema-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/olema-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/olema-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/olema-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/olema-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/olema-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/olema-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/olema-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/olema-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/olema-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/olema-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/olema-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/olema-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/olema-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/olema-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=events - `alpha://company/olema-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/olema-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/olema-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating and Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:yi-larson-olma","name":"Yi Larson"},"source_id":"governance_people_committees"}` ## Leadership - Ian Clark: Chairperson of the Board. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c76f6963450b7442d53a7d650c43c4fb33ccf521b9978fa11add3dad3d2e299. - Andrew Rappaport: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:6. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c7d15bcdb7cad415a7b1ce365acf65f82fc75cada5d2d9546d87de7a40ddcc3. - Cynthia Butitta: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:7. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c7d15bcdb7cad415a7b1ce365acf65f82fc75cada5d2d9546d87de7a40ddcc3. - Cyrus L. Harmon: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:8. Valid from: 2006-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c7d15bcdb7cad415a7b1ce365acf65f82fc75cada5d2d9546d87de7a40ddcc3. - Cyrus L. Harmon, Ph.D.: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c76f6963450b7442d53a7d650c43c4fb33ccf521b9978fa11add3dad3d2e299. - Gorjan Hrustanovic: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:10. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c7d15bcdb7cad415a7b1ce365acf65f82fc75cada5d2d9546d87de7a40ddcc3. - Gorjan Hrustanovic, Ph.D.: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c76f6963450b7442d53a7d650c43c4fb33ccf521b9978fa11add3dad3d2e299. - Graham Walmsley: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:12. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c7d15bcdb7cad415a7b1ce365acf65f82fc75cada5d2d9546d87de7a40ddcc3. - Graham Walmsley, M.D., Ph.D.: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c76f6963450b7442d53a7d650c43c4fb33ccf521b9978fa11add3dad3d2e299. - Prakash Raman: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:14. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c7d15bcdb7cad415a7b1ce365acf65f82fc75cada5d2d9546d87de7a40ddcc3. - Prakash Raman, Ph.D.: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c76f6963450b7442d53a7d650c43c4fb33ccf521b9978fa11add3dad3d2e299. - Sandra Horning, M.D.: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c76f6963450b7442d53a7d650c43c4fb33ccf521b9978fa11add3dad3d2e299. - Sandra J. Horning: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:17. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c7d15bcdb7cad415a7b1ce365acf65f82fc75cada5d2d9546d87de7a40ddcc3. - Scott Garland: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:18. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c7d15bcdb7cad415a7b1ce365acf65f82fc75cada5d2d9546d87de7a40ddcc3. - Sean Bohen, M.D., Ph.D.: Director, President and Chief Executive Officer. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c76f6963450b7442d53a7d650c43c4fb33ccf521b9978fa11add3dad3d2e299. - Yi Larson: Director. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:20. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9c7d15bcdb7cad415a7b1ce365acf65f82fc75cada5d2d9546d87de7a40ddcc3. - David C. Myles, Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c76f6963450b7442d53a7d650c43c4fb33ccf521b9978fa11add3dad3d2e299. - Naseem Zojwalla, M.D.: Chief Medical Officer. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c76f6963450b7442d53a7d650c43c4fb33ccf521b9978fa11add3dad3d2e299. - Sean Bohen, M.D., Ph.D.: President and Chief Executive Officer. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c76f6963450b7442d53a7d650c43c4fb33ccf521b9978fa11add3dad3d2e299. - Shane Kovacs: Chief Operating and Financial Officer. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c76f6963450b7442d53a7d650c43c4fb33ccf521b9978fa11add3dad3d2e299. - Shawnte M. Mitchell, J.D.: Chief Legal Officer and Corporate Secretary. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:leadership_role:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4c76f6963450b7442d53a7d650c43c4fb33ccf521b9978fa11add3dad3d2e299. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Nominating and Committee: Chair not stated; Members Yi Larson. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:committee_record:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:56500fef3c292701d438be1a916c561f3dc3a1b9fea1edd5f15fe5f8194549b0. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Olema Pharmaceuticals, Inc.. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:64c802f7914b63c24859da37200b92b603a47181386a78e87156f1736d04f570. ## Entity Status - Public listing published. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:64c802f7914b63c24859da37200b92b603a47181386a78e87156f1736d04f570. ## Published Fact - US. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:64c802f7914b63c24859da37200b92b603a47181386a78e87156f1736d04f570. ## Committee Appointment - Yi Larson: member, Nominating and Committee. Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:56500fef3c292701d438be1a916c561f3dc3a1b9fea1edd5f15fe5f8194549b0. ## Security Listing - OLMA (NASDAQ). Claim: alpha:claim:company:0aab76ee-08e1-4366-8ddd-a1d9c421e63f:security_listing:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:64c802f7914b63c24859da37200b92b603a47181386a78e87156f1736d04f570. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:64c802f7914b63c24859da37200b92b603a47181386a78e87156f1736d04f570: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/olema-pharmaceuticals-inc). - alpha:projection-evidence:document:4c76f6963450b7442d53a7d650c43c4fb33ccf521b9978fa11add3dad3d2e299: [SEC DEF 14A 0001193125-26-191956](https://www.sec.gov/Archives/edgar/data/1750284/000119312526191956/olma-20260429.htm). - alpha:projection-evidence:document:9c7d15bcdb7cad415a7b1ce365acf65f82fc75cada5d2d9546d87de7a40ddcc3: [DEF 14A olma-20260429.htm](https://www.sec.gov/Archives/edgar/data/1750284/000119312526191956/olma-20260429.htm). - alpha:projection-evidence:56500fef3c292701d438be1a916c561f3dc3a1b9fea1edd5f15fe5f8194549b0: [Nominating and Committee](https://www.sec.gov/Archives/edgar/data/1750284/000119312526191956/olma-20260429.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/olema-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/olema-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/olema-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/olema-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-22T08:33:37.994201+00:00; recorded 2026-10-22T08:33:37.994201+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.